$276,059,721
to THE JOHNS HOPKINS UNIVERSITY
INTERNATIONAL MATERNAL PEDIATRIC ADOLESCENT AIDS CLINICAL TRIALS (IMPAACT) GROUP
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Latest obligation on the IMPAACT clinical trials network studying HIV/AIDS treatments in mothers, children, and adolescents across international sites.
IMPAACT is a 20-year-old NIH cooperative agreement generating evidence on pediatric and maternal HIV care in resource-limited settings, directly informing global treatment guidelines.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-22. Cost: $0.002786.
- 2026-04-06NATIONAL STUDY OF DISABILITY TRENDS AND DYNAMICS$169.4M
- 2026-04-06ECHODAC (ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES DATA ANALYSIS CENTER)$134.4M
- 2026-04-20ENHANCING GLOBAL HEALTH SECURITY: EXPANDING EFFORTS AND STRATEGIES TO PROTECT AND IMPROVE PUBLIC HEALTH GLOBALLY$64.3M
- 2026-04-06THE JOHNS HOPKINS CENTER FOR AIDS RESEARCH (JHU CFAR)$60.9M
- 2026-04-20NORTH AMERICAN AIDS COHORTS COLLABORATION ON RESEARCH AND DESIGN$57.9M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI068632_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.